The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Open accessAbstract
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCR5, another chemokine receptor with similar homing properties, has been also used to identify these cells [144, 145], but it is expressed only on the more differentiated Th1 effector memory population [146].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193
Self-citationThe lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Self-citationA highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Current protocols in immunology
Nezlin, R. S. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,413
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Self-citation
Cited by
Sorted by citations
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
Chamberlain, G., Fox, J. M., Ashton, B. A., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,432
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,535
Self-citationT-Cell Function and Migration — Two Sides of the Same Coin
von Andrian, U. H., & Mackay, C. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431407 · Cited by 1,429
Self-citationGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Lymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,253
Self-citationDufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,054
Self-citationCXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,006
Sørensen, T. L., Tani, M., Jensen, J. S., Pierce, V., Lucchinetti, C. F., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F. T., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 994
Self-citationGroom, J. R., & Luster, A. D. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.017 · Cited by 1,005
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B. J., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 923
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
Sallusto, F., Lanzavecchia, A., & Mackay, C. R. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01346-2 · Cited by 888
Self-citationBachelerie, F., Ben‐Baruch, A., Burkhardt, A. M., Combadière, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre‐Ulrich, A. H., Locati, M., Luster, A. D., et al. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 888
Chemokines: immunology's high impact factors
Mackay, C. R. (2001) · Nature Immunology · doi:10.1038/84298 · Cited by 842
Self-citationThe chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J. B., Qin, S., Ponath, P. D., Andrew, D. P., Warnke, R. A., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 833
Self-citationCXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 822
Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783
Chemokines and chemokine receptors in leukocyte trafficking
Olson, T. S., & Ley, K. F. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00738.2001 · Cited by 670
Kaempferol and inflammation: from chemistry to medicine
Devi, K. P., Malar, D. S., Nabavi, S. F., Sureda, A., Xiao, J., Nabavi, S. M., & Daglia, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.002 · Cited by 619
The immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 594
T Cell Dynamics in HIV-1 Infection
Douek, D. C., Picker, L. J., & Koup, R. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141053 · Cited by 579
Neutrophil-Derived Proteins: Selling Cytokines by the Pound
Cassatella, M. A. (1999) · Advances in immunology · doi:10.1016/s0065-2776(08)60791-9 · Cited by 558
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Role of chemokines in the biology of natural killer cells
Robertson, M. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.2.173 · Cited by 515
Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520
Pathogenesis of HIV infection: what the virus spares is as important as what it destroys
Grossman, Z., Meier‐Schellersheim, M., Paul, W. E., & Picker, L. J. (2006) · Nature Medicine · doi:10.1038/nm1380 · Cited by 518
Fox, J. G., Beck, P. L., Dangler, C. A., Whary, M. T., Wang, T. C., Shi, H. N., & Nagler‐Anderson, C. (2000) · Nature Medicine · doi:10.1038/75015 · Cited by 489
Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity
Lugade, A. A., Sorensen, E. W., Gerber, S. A., Moran, J. P., Frelinger, J. G., & Lord, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3132 · Cited by 485
Zabel, B. A., Agace, W. W., Campbell, J. J., Heath, H., Parent, D., Roberts, A. I., Ebert, E. C., Kassam, N., Qin, S., Zovko, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1241 · Cited by 485
Self-citationHollern, D. P., Xu, N., Thennavan, A., Glodowski, C. R., García‐Recio, S., Mott, K. R., He, X., Garay, J. P., Carey-Ewend, K., Marron, D. L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.028 · Cited by 480
Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K. S., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 466
D’Ambrosio, D., Iellem, A., Bonecchi, R., Mazzeo, D., Sozzani, S., Mantovani, A., & Sinigaglia, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5111 · Cited by 461
Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice
Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E. I., Plachý, J., Brühl, H., Frink, M., Anders, H., Vielhauer, V., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4697 · Cited by 459
Nanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S., & Lipsky, P. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6590 · Cited by 450
Panina‐Bordignon, P., Papi, A. A., Mariani, M., Lucia, P. D., Casoni, G. L., Bellettato, C. M., Buonsanti, C., Miotto, D., Mapp, C. E., Villa, A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12655 · Cited by 442
The emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
Yoshie, O., Imai, T., & Nomiyama, H. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78002-9 · Cited by 430
Shields, P. L., Morland, C. M., Salmon, M., Qin, S., Hübscher, S. G., & Adams, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6236 · Cited by 424
Self-citationCXC chemokines in angiogenesis
Strieter, R. M., Burdick, M. D., Gomperts, B. N., Belperio, J. A., & Keane, M. P. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.04.007 · Cited by 430
Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F., & Campbell, D. J. (2012) · Blood · doi:10.1182/blood-2011-11-392324 · Cited by 413
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 434
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 415
The emerging role of CXCL10 in cancer (Review)
Liu, M., Guo, S., & Stiles, J. K. (2011) · Oncology Letters · doi:10.3892/ol.2011.300 · Cited by 425
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B. N., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 419
Differential chemokine receptor expression and function in human monocyte subpopulations
Weber, C., Belge, K.-U., von Hundelshausen, P., Draude, G., Steppich, B., Mack, M., Frankenberger, M., Weber, K. S. C., & Ziegler-Heitbrock, H. W. L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.699 · Cited by 425
Ward, S. G., Bacon, K. B., & Westwick, J. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80583-x · Cited by 397
Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis
Spergel, J. M., Mizoguchi, E., Oettgen, H. C., Bhan, A. K., & Geha, R. S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5669 · Cited by 383
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 377
Sauty, A., Dziejman, M., Taha, R. A., Iarossi, A. S., Neote, K. S., García-Zepeda, E. A., Hamid, Q. A., & Luster, A. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3549 · Cited by 373
Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N., & Luster, A. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.975 · Cited by 373
Hauser, A. E., Debes, G. F., Arce, S., Cassese, G., Hamann, A., Radbruch, A., & Manz, R. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1277 · Cited by 362
Are some breast carcinomas polyclonal in origin?
Heim, S., Teixeira, M. R., & Pandis, N. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200108)194:4 · Cited by 16
Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α
Lauzurica, P., Martı́nez-Martı́nez, S., Marazuela, M., Arco, P. G., Martínez‐A, C., Sánchez‐Madrid, F., & Redondo, J. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06 · Cited by 71
Self-citation(2003) · PubMed · Cited by 355
Noss, E. H., & Brenner, M. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00648.x · Cited by 359
Kim, C. H., Kunkel, E. J., Boisvert, J., Johnston, B., Campbell, J. J., Genovese, M. C., Greenberg, H. B., & Butcher, E. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11902 · Cited by 352
Gamonal, J. A., Acevedo, A., Bascones, A., Jorge, O., & Silva, A. H. L. (2000) · Journal of Periodontology · doi:10.1902/jop.2000.71.10.1535 · Cited by 353
Survival of long-lived plasma cells is independent of antigen [In Process Citation]
Manz, R. A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1703 · Cited by 348
Horuk, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00014-4 · Cited by 348
Ma, C. S., Suryani, S., Avery, D. T., Chan, A., Nanan, R. K. H., Santner‐Nanan, B., Deenick, E. K., & Tangye, S. G. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.64 · Cited by 358
Chemokines: signal lamps for trafficking of T and B cells for development and effector function
Kim, C. H., & Broxmeyer, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.6 · Cited by 338
Lünemann, J. D., Jelčić, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martinꝉ, R., & Münz, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072397 · Cited by 348
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 340
Chemokines in the systemic organization of immunity
Campbell, D. J., Kim, C. H., & Butcher, E. C. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00067.x · Cited by 330
CXCR3 and CCR5 Ligands in Rheumatoid Arthritis Synovium
Patel, D. D., Zachariah, J. P., & Whichard, L. P. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4957 · Cited by 328
Yoshie, O., Fujisawa, R., Nakayama, T., Harasawa, H., Tago, H., Izawa, D., Hieshima, K., Tatsumi, Y., Matsushima, K., Hasegawa, H., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1505 · Cited by 326
Buckley, C. D., Amft, N., Bradfield, P. F., Pilling, D., Ross, E. A., Arenzana‐Seisdedos, F., Amara, A., Curnow, J., Lord, J. M., Scheel‐Toellner, D., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3423 · Cited by 325
Metzemaekers, M., Vanheule, V., Janssens, R., Struyf, S., & Proost, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01970 · Cited by 335
The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3
Loetscher, P., Pellegrino, A., Gong, J.-H., Mattioli, I., Loetscher, M., Bardi, G., Baggiolini, M., & Clark‐Lewis, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005652200 · Cited by 316
Self-citationLeukocyte migration and graft-versus-host disease
Wysocki, C., Panoskaltsis‐Mortari, A., Blazar, B. R., & Serody, J. S. (2005) · Blood · doi:10.1182/blood-2004-12-4726 · Cited by 323
Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L. M., Olsen, H. S., Murphy, M., Liao, F., Farber, J. M., & Cassatella, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4928 · Cited by 314
CXCR5 Expressing Human Central Memory CD4 T Cells and Their Relevance for Humoral Immune Responses
Chevalier, N., Jarrossay, D., Ho, E. C., Avery, D. T., Ma, C. S., Yu, D., Sallusto, F., Tangye, S. G., & Mackay, C. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002828 · Cited by 326
Self-citationGlucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01744 · Cited by 308
Rowe, A. M., Leger, A. J. S., Jeon, S., Dhaliwal, D. K., Knickelbein, J. E., & Hendricks, R. L. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.08.002 · Cited by 303
IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
Ng, L. F. P., Chow, A. L., Sun, Y.-J., Kwek, D. J. C., Lim, P., Dimatatac, F., Ng, L. C., Ooi, E. E., Choo, K. H., Her, Z., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004261 · Cited by 302
Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation
Randolph, D. A., Stephens, R., Carruthers, C. J. L., & Chaplin, D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7631 · Cited by 301
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
Jiang, D., Liang, J., Hodge, J. A., Lu, B., Zhu, Z., Yu, S., Fan, J., Gao, Y., Yin, Z., Homer, R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci16861 · Cited by 303
Murai, M., Yoneyama, H., Harada, A., Zhang, Y., Vestergaard, C., Guo, B., Suzuki, K., Asakura, H., & Matsushima, K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6642 · Cited by 298
Ruschpler, P., Lorenz, P., Eichler, W., Koczan, D., Hänel, C., Scholz, R., Melzer, C., Thiesen, H., & Stiehl, P. (2003) · Arthritis Research & Therapy · doi:10.1186/ar783 · Cited by 292
White, G. E., Iqbal, A. J., & Greaves, D. R. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005074 · Cited by 295
Rivino, L., Messi, M., Jarrossay, D., Lanzavecchia, A., Sallusto, F., & Geginat, J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040774 · Cited by 298
Expression and regulation of chemokine receptors in human natural killer cells
Inngjerdingen, M., Damaj, B. B., & Maghazachi, A. A. (2001) · Blood · doi:10.1182/blood.v97.2.367 · Cited by 287
Youn, J., Yu, H. T., Lim, B. J., Koh, M. J., Lee, J., Chang, D.-Y., Choi, Y. S., Lee, S., Kang, S., Jang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00689 · Cited by 289
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
Jäger, A., & Kuchroo, V. K. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02432.x · Cited by 296
IP-10 Is Critical for Effector T Cell Trafficking and Host Survival in Toxoplasma gondii Infection
Khan, I. A., MacLean, J. A., Lee, F. S., Casciotti, L., DeHaan, E. N., Schwartzman, J. D., & Luster, A. D. (2000) · Immunity · doi:10.1016/s1074-7613(00)80200-9 · Cited by 281
Howard, O. M. Z., Dong, H., Yang, D., Raben, N., Nagaraju, K., Rosen, A., Casciola-Rosen, L. A., Haertlein, M., Kron, M., Yang, D. C. H., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020186 · Cited by 279
Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function
Colvin, R. A., Campanella, G. S. V., Sun, J., & Luster, A. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403595200 · Cited by 276
Xia, M. Q., Bacskai, B. J., Knowles, R. B., Qin, S. X., & Hyman, B. T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00285-x · Cited by 269
Self-citationChemokines: attractive mediators of the immune response
Wong, M., & Fish, E. N. (2002) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00123-9 · Cited by 270
Rabin, R. L., Park, M. K., Liao, F., Swofford, R., Stephany, D., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3840 · Cited by 266
Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
Hricik, D. E., Nickerson, P. W., Formica, R. N., Poggio, E. D., Rush, D. N., Newell, K. A., Goebel, J., Gibson, I. W., Fairchild, R. L., Riggs, M. R., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12426 · Cited by 265
A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility
Kochi, Y., Okada, Y., Suzuki, A., Ikari, K., Terao, C., Takahashi, A., Yamazaki, K., Hosono, N., Myouzen, K., Tsunoda, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.583 · Cited by 268
Sørensen, T. L., Trebst, C., Kivisäkk, P., Klaege, K. L., Majmudar, A., Ravid, R., Lassmann, H., Olsen, D. B., Strieter, R. M., Ransohoff, R. M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00097-8 · Cited by 262
Kawasaki, S., Takizawa, H., Yoneyama, H., Nakayama, T., Fujisawa, R., Izumizaki, M., Imai, T., Yoshie, O., Homma, I., Yamamoto, K., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2055 · Cited by 261
Parlato, S., Santini, S. M., Lapenta, C., Pucchio, T. D., Logozzi, M., Spada, M., Giammarioli, A. M., Malorni, W., Fais, S., & Belardelli, F. (2001) · Blood · doi:10.1182/blood.v98.10.3022 · Cited by 259
CXC Chemokines in Cancer Angiogenesis and Metastases
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06003-3 · Cited by 263
Weinreich, M. A., Odumade, O. A., Jameson, S. C., & Hogquist, K. A. (2010) · Nature Immunology · doi:10.1038/ni.1898 · Cited by 262
Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., & Karpus, W. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7617 · Cited by 255
Metadata
- Authors
- Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Bern (CH)
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-15
- Volume
- 101
- Issue
- 4
- Pages
- 746-754
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508621
- OpenAlex
- W2081596482
- Cited by
- 1,359
- References
- 39
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 11 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 23 · 2019: 33 · 2018: 32 · 2017: 33 · 2016: 24 · 2015: 46 · 2014: 52 · 2013: 38 · 2012: 45
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- CXCR3, CCR5, chemokine receptors, T cell subsets, T cell homing, inflammatory cell infiltration, Th1 response, CXCL10, RANTES, CCL22, CCL19, CD45RO, beta1 integrin, T cell migration, lymph node T cells
- MeSH terms
- Animals, Antibodies, Monoclonal, Chemotaxis, Humans, Immunologic Memory, Inflammation, Leukocytes, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Synovial Fluid, Tumor Cells, Cultured, Biomarkers, T-Lymphocyte Subsets, Chemokines, Receptors, Chemokine, Receptors, CCR5, Chemokines, CXC, Mice, Chemokine CXCL10, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review